Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease
Author(s) -
Andrea S. Gershon,
Michael A. Campitelli,
Ruth Croxford,
Matthew B. Stanbrook,
Teresa To,
Ross Upshur,
Anne L. Stephenson,
Thérèse A. Stukel
Publication year - 2014
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2014.11432
Subject(s) - medicine , copd , propensity score matching , medical prescription , cohort study , cohort , population , pulmonary disease , physical therapy , intensive care medicine , emergency medicine , environmental health , pharmacology
Chronic obstructive pulmonary disease (COPD), a manageable respiratory condition, is the third leading cause of death worldwide. Knowing which prescription medications are the most effective in improving health outcomes for people with COPD is essential to maximizing health outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom